Nurse AMIE for Echo Show: Randomized Control Trial
NCT04673019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2022-04-01
Summary
The Nurse AMIE platform has been modified for use as an Amazon Alexa skill for use on the Echo Show device. The investigators will recruit women receiving treatment for metastatic breast cancer and randomize patients to receive standard treatment (control) or the Nurse AMIE for Echo Show program. Nurse AMIE is a supportive care program for women undergoing chemotherapy and helps manage symptoms. The investigators will test the feasibility of using the Nurse AMIE program as well as its effectiveness at managing symptoms.
Conditions
Interventions
- BEHAVIORAL
-
Nurse AMIE (Addressing Metastatic Individuals Every day)
Supportive Care Platform (behavioral interventions that are offered based on answers to daily symptom rating questions). Interventions offered include walking, balance, strength exercise, guided relaxation, CBT, DBT, soothing music.
Sponsors & Collaborators
-
Penn State University
collaborator OTHER -
American Institute for Cancer Research
collaborator OTHER -
Milton S. Hershey Medical Center
lead OTHER
Principal Investigators
-
Kathryn H Schmitz, PhD · Penn State Milton Hershey Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-02
- Primary Completion
- 2022-02-28
- Completion
- 2022-02-28
Countries
- United States
Study Locations
More Related Trials
-
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
NCT02115282 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT00003927 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
NCT00004092 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
NCT00003893 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
NCT04352777 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00003352 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer
NCT00189670 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12
NCT00194753 ·Status: COMPLETED ·Phase: PHASE2
-
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
NCT04084730 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer
NCT05716893 ·Status: RECRUITING ·Phase: PHASE2
-
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy
NCT04305613 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
NCT02535221 ·Status: RECRUITING ·Phase: PHASE3
-
Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
NCT00070031 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
NCT00295893 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
NCT03573648 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
NCT02689921 ·Status: UNKNOWN ·Phase: PHASE2
-
Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
NCT00232479 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00003519 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer
NCT00242203 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063 ·Status: COMPLETED ·Phase: NA
-
Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients
NCT04638712 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
NCT03647280 ·Status: UNKNOWN ·Phase: NA
-
A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
NCT05257395 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
NCT03373708 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
NCT00872625 ·Status: COMPLETED ·Phase: PHASE1